subscribeSubscribe
Ipsen`s Biologic Dysport (AbobotulinumtoxinA) Receives Approval in the U.S.

Ipsen`s Biologic Dysport (AbobotulinumtoxinA) Receives Approval in the U.S.
FDA
21 Sep 2023
Share Share
Daewoong’s botulinum toxin wins `world’s 1st` nod to treat square jaw

Daewoong’s botulinum toxin wins `world’s 1st` nod to treat square jaw
KOREA BIOMED
28 Aug 2023
Share Share
AEON Receives Notice of Allowance for a Patent Covering Use of Botulinum Toxins

AEON Receives Notice of Allowance for a Patent Covering Use of Botulinum Toxins
GLOBENEWSWIRE
24 Aug 2023
Share Share
Medytox`s BTX patent could face invalidation trial in US

Medytox`s BTX patent could face invalidation trial in US
KOREAHERALD
04 Mar 2023
Share Share
Ipsen` Biologic DYSPORT (AbobotulinumtoxinA) Receives Approval in the U.S.

Ipsen` Biologic DYSPORT (AbobotulinumtoxinA) Receives Approval in the U.S.
FDA
12 Jan 2023
Share Share
Hugel resubmits BLA for botulinum toxin, Botulax to US FDA

Hugel resubmits BLA for botulinum toxin, Botulax to US FDA
PHARMABIZ
08 Oct 2022
Share Share
Aeon hits phase 2 goals in rare disorder

Aeon hits phase 2 goals in rare disorder
Gabrielle Masson FIERCEBIOTECH
24 Sep 2022
Share Share
Galderma posts phase 3 wins for botulinum toxin A on path to FDA

Galderma posts phase 3 wins for botulinum toxin A on path to FDA
Nick Paul Taylor FIERCEPHARMA
15 Jun 2022
Share Share
DelNova Advances ReViVox to Reverse Botulinum Toxin Neuromodulator Complications

DelNova Advances ReViVox to Reverse Botulinum Toxin Neuromodulator Complications
PRNEWSWIRE
01 Apr 2022
Share Share
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
PRNEWSWIRE
24 Mar 2022
Share Share